Literature DB >> 16883555

Differential role of Presenilin-1 and -2 on mitochondrial membrane potential and oxygen consumption in mouse embryonic fibroblasts.

Homira Behbahani1, Irina G Shabalina, Birgitta Wiehager, Hérnan Concha, Kjell Hultenby, Natasa Petrovic, Jan Nedergaard, Bengt Winblad, Richard F Cowburn, Maria Ankarcrona.   

Abstract

Increasing evidence indicates that mitochondrial alterations contribute to the neuronal death in Alzheimer's disease (AD). Presenilin 1 (PS1) and Presenilin 2 (PS2) mutations have been shown to sensitize cells to apoptosis by mechanisms suggested to involve impaired mitochondrial function. We have previously detected active gamma-secretase complexes in mitochondria. We investigated the impact of PS/gamma-secretase on mitochondrial function using mouse embryonal fibroblasts derived from wild-type, PS1-/-, PS2-/- and PS double knock-out (PSKO) embryos. Measurements of mitochondrial membrane potential (DeltaPsim) showed a higher percentage of fully functional mitochondria in PS1-/- and PSwt as compared to PS2-/- and PSKO cells. This result was evident both in whole cell preparations and in isolated mitochondria. Interestingly, pre-treatment of isolated mitochondria with the gamma-secretase inhibitor L-685,458 resulted in a decreased population of mitochondria with high DeltaPsim in PSwt and PS1-/- cells, indicating that PS2/gamma-secretase activity can modify DeltaPsim. PS2-/- cells showed a significantly lower basal respiratory rate as compared to other cell lines. However, all cell lines demonstrated competent bioenergetic function. These data point toward a specific role of PS2/gamma-secretase activity for proper mitochondrial function and indicate interplay between PS1 and PS2 in mitochondrial functionality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16883555     DOI: 10.1002/jnr.20990

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  20 in total

Review 1.  Mitochondrial Ca²⁺ homeostasis: mechanism, role, and tissue specificities.

Authors:  Paola Pizzo; Ilaria Drago; Riccardo Filadi; Tullio Pozzan
Journal:  Pflugers Arch       Date:  2012-06-16       Impact factor: 3.657

2.  Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk.

Authors:  Enrico Zampese; Cristina Fasolato; Maulilio J Kipanyula; Mario Bortolozzi; Tullio Pozzan; Paola Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-01       Impact factor: 11.205

Review 3.  Mitochondrial medicine for aging and neurodegenerative diseases.

Authors:  P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2008-06-20       Impact factor: 3.843

Review 4.  Impact of Genetic Risk Factors for Alzheimer's Disease on Brain Glucose Metabolism.

Authors:  Sukhee Cho; Hyein Lee; Jinsoo Seo
Journal:  Mol Neurobiol       Date:  2021-01-21       Impact factor: 5.590

5.  Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice.

Authors:  Darrell Sawmiller; Ahsan Habib; Song Li; Donna Darlington; Huayan Hou; Jun Tian; R Douglas Shytle; Adam Smith; Brian Giunta; Takashi Mori; Jun Tan
Journal:  J Neuroimmunol       Date:  2016-09-01       Impact factor: 3.478

6.  RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling.

Authors:  Bei Liu; Liang Wang; Liang-Liang Shen; Ming-Zhi Shen; Xiao-Dong Guo; Tao Wang; Qin-Chuan Liang; Chao Wang; Jun Zheng; Yi Li; Lin-Tao Jia; Hua Zhang; Guo-Dong Gao
Journal:  Neuro Oncol       Date:  2012-06-29       Impact factor: 12.300

Review 7.  Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.

Authors:  Anne Eckert; Kathrin L Schulz; Virginie Rhein; Jürgen Götz
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

8.  TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3.

Authors:  Ge Li; Lynn M Bekris; Lesley Leong; Ellen J Steinbart; Jane B Shofer; Paul K Crane; Eric B Larson; Elaine R Peskind; Thomas D Bird; Chang-En Yu
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

Review 9.  Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?

Authors:  Bo Su; Xinglong Wang; David Bonda; Gorge Perry; Mark Smith; Xiongwei Zhu
Journal:  Mol Neurobiol       Date:  2010-01-27       Impact factor: 5.590

Review 10.  Deconstructing mitochondrial dysfunction in Alzheimer disease.

Authors:  Vega García-Escudero; Patricia Martín-Maestro; George Perry; Jesús Avila
Journal:  Oxid Med Cell Longev       Date:  2013-06-11       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.